...
首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >The synthesis of [carboxamido-~(14)C]SAR240550, [carnoxamido-~(14)C]lniparib, via monocarboxylation of 1,4-diiodobenzene
【24h】

The synthesis of [carboxamido-~(14)C]SAR240550, [carnoxamido-~(14)C]lniparib, via monocarboxylation of 1,4-diiodobenzene

机译:通过1,4-二碘苯的单羧化反应合成[羧酰胺基〜(14)C] SAR240550,[羧酰胺基~~(14)C]

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Iniparib (SAR240550,4-iodo-3-nitrobenzamide) is a novel investi-gational agent for the treatment of various cancers.1 The potential chemotherapeutic activity of this compound has long been recognised.2 To enable ADME (absorption, distribution, metabolism and elimination) and human studies, [carboxamido-~(14)C] SAR240550 (1) was required. As initial metabolic studies had indicated that the amide carbon was metabolically stable, we decided that labelling in that position would be appropriate.
机译:Iniparib(SAR240550,4-iodo-3-nitrobenzamide)是用于治疗各种癌症的新型研究药物。1长期以来,该化合物的潜在化学治疗活性已被人们认识到。2使ADME(吸收,分布,代谢和代谢)成为可能。 (carboxamido-〜(14)C] SAR240550(1)是必需的。由于最初的代谢研究表明酰胺碳在代谢上是稳定的,因此我们认为在该位置进行标记是合适的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号